S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
Laser breakthrough could send stock soaring 2,467% (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Laser breakthrough could send stock soaring 2,467% (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
Laser breakthrough could send stock soaring 2,467% (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Laser breakthrough could send stock soaring 2,467% (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
Laser breakthrough could send stock soaring 2,467% (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Laser breakthrough could send stock soaring 2,467% (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
Laser breakthrough could send stock soaring 2,467% (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Laser breakthrough could send stock soaring 2,467% (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
LON:BXP

Beximco Pharmaceuticals (BXP) Share Forecast, Price & News

GBX 39
0.00 (0.00%)
(As of 05/31/2023 ET)
Compare
Today's Range
38.25
39
50-Day Range
37.50
44.85
52-Week Range
37
85
Volume
7,298 shs
Average Volume
49,375 shs
Market Capitalization
£173.98 million
P/E Ratio
557.14
Dividend Yield
7.69%
Price Target
N/A

BXP stock logo

About Beximco Pharmaceuticals (LON:BXP) Stock

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BXP Stock News Headlines

Is This The End Of Your Retirement?
Soon, the U.S. Government is going to make an announcement that could radically alter your retirement. Two of America's largest banks - Goldman Sachs and J.P. Morgan - have quietly warned their richest clients to prepare for it. The clock is ticking. Find out How to Protect Yourself from the Greatest Crisis Facing Retirees in 70 Years before it's too late.
Beximco Pharmaceuticals
Beximco Pharmaceuticals Ltd.
Beximco Pharmaceuticals Ltd (BXPH)
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Beximco Pharmaceuticals Ltd. GDR
Beximco Pharma Share Chat
Beximco Pharmaceut - Price Monitoring Extension
Beximco Pharma Share News (BXP)
Sanofi selects Beximco as potential buyer
Beximco Pharmaceuticals Limited (BXP.L)
See More Headlines
Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
£173.98 million
Optionable
Optionable
Beta
0.74

Key Executives

  • Mr. Md. Nazmul Hassan MP
    MD & Director
  • Mr. Mohammad Ali Nawaz
    Chief Financial Officer
  • Mr. S. M. Rabbur Reza
    Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury
    Director of Accounts & Fin.
  • Mr. Rizvi Ul Kabir
    Director of Marketing
  • Mr. M. A. Arshad Bhuiyan
    Gen. Mang. of HR
  • Mr. Zakaria Seraj Chowdhury
    Head of Distribution Services & Director of International Marketing
  • Mr. Mohammad Asad Ullah FCS
    Company Sec. & Exec. Director
  • Mr. Prabir Ghose
    Exec. Director of Quality Assurance













BXP Stock - Frequently Asked Questions

How have BXP shares performed in 2023?

Beximco Pharmaceuticals' stock was trading at GBX 54 on January 1st, 2023. Since then, BXP stock has decreased by 27.8% and is now trading at GBX 39.
View the best growth stocks for 2023 here
.

Is Beximco Pharmaceuticals a good dividend stock?

Beximco Pharmaceuticals (LON:BXP) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 7.24%. BXP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,285.71%. Payout ratios above 75% are not desirable because they may not be sustainable.

What is Beximco Pharmaceuticals' stock symbol?

Beximco Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

How do I buy shares of Beximco Pharmaceuticals?

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Beximco Pharmaceuticals' stock price today?

One share of BXP stock can currently be purchased for approximately GBX 39.

How much money does Beximco Pharmaceuticals make?

Beximco Pharmaceuticals (LON:BXP) has a market capitalization of £173.98 million.

How many employees does Beximco Pharmaceuticals have?

The company employs 5,500 workers across the globe.

How can I contact Beximco Pharmaceuticals?

Beximco Pharmaceuticals' mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The official website for the company is www.beximco-pharma.com. The company can be reached via phone at +880-2-58611001.

This page (LON:BXP) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -